IE812075L - Composition - Google Patents
CompositionInfo
- Publication number
- IE812075L IE812075L IE812075A IE207581A IE812075L IE 812075 L IE812075 L IE 812075L IE 812075 A IE812075 A IE 812075A IE 207581 A IE207581 A IE 207581A IE 812075 L IE812075 L IE 812075L
- Authority
- IE
- Ireland
- Prior art keywords
- composition
- admixture
- solid
- pharmaceutical composition
- surface area
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
1. A solid pharmaceutical composition containing as the active ingredient nifedipine crystals with a specific surface area of 0,5 to 6 m**2 /g, in admixture with a solid diluent.
[EP0047899A1]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803033919 DE3033919A1 (en) | 1980-09-09 | 1980-09-09 | SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
IE812075L true IE812075L (en) | 1982-03-09 |
IE51549B1 IE51549B1 (en) | 1987-01-07 |
Family
ID=6111496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2075/81A IE51549B1 (en) | 1980-09-09 | 1981-09-08 | Solid medicament formulations containing nifedipine,and processes for their preparation |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0047899B2 (en) |
JP (1) | JPS5914446B2 (en) |
AR (1) | AR226377A1 (en) |
AT (1) | ATE5761T1 (en) |
AU (1) | AU558331B2 (en) |
CA (1) | CA1180277A (en) |
DD (1) | DD201974A5 (en) |
DE (2) | DE3033919A1 (en) |
DK (1) | DK154326C (en) |
FI (1) | FI72648B (en) |
GR (1) | GR78237B (en) |
HU (1) | HU184879B (en) |
IE (1) | IE51549B1 (en) |
IL (1) | IL63749A (en) |
NO (1) | NO157368B (en) |
NZ (1) | NZ198285A (en) |
PH (1) | PH24097A (en) |
PL (1) | PL232951A1 (en) |
PT (1) | PT73603B (en) |
ZA (1) | ZA816213B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264446A (en) * | 1980-09-09 | 1993-11-23 | Bayer Aktiengesellschaft | Solid medicament formulations containing nifedipine, and processes for their preparation |
JPS5846019A (en) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | Nifedipine preparation with prolonged action |
DE3222367A1 (en) * | 1982-06-15 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Use of 1,4-dihydropyridines in antiarteriosclerotics and preparation thereof |
JPS59101423A (en) * | 1982-12-02 | 1984-06-12 | Takada Seiyaku Kk | Novel solid pharmaceutical preparation of nifedipine |
US4529733A (en) * | 1983-04-06 | 1985-07-16 | Merrell Dow Pharmaceuticals Inc. | Antihypertensive 3-furoyl-1,4-dihydropyridines |
DE3318649A1 (en) * | 1983-05-21 | 1984-11-22 | Bayer Ag, 5090 Leverkusen | TWO-PHASE FORMULATION |
NL194389C (en) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier. |
IT1178511B (en) * | 1984-09-14 | 1987-09-09 | Pharmatec Spa | PROCEDURE FOR THE PREPARATION OF A SOLID FORM FOR ORAL USE BASED ON NIFEDIPINE WITH RELEASE |
IT1187751B (en) * | 1985-10-15 | 1987-12-23 | Eurand Spa | PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED |
US4940556A (en) * | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
US5198226A (en) * | 1986-01-30 | 1993-03-30 | Syntex (U.S.A.) Inc. | Long acting nicardipine hydrochloride formulation |
CH673947A5 (en) * | 1986-09-23 | 1990-04-30 | Sandoz Ag | |
JPS6464659A (en) * | 1987-09-03 | 1989-03-10 | Kenbi Kogaku Kenkyusho Kk | Preparation of safe and effective powder formulation |
SE8703881D0 (en) * | 1987-10-08 | 1987-10-08 | Haessle Ab | NEW PHARMACEUTICAL PREPARATION |
DE3814532A1 (en) * | 1988-04-29 | 1989-11-09 | Bayer Ag | DHP-RETARD-PREPARATION |
JPH0298550U (en) * | 1989-01-25 | 1990-08-06 | ||
GB8903328D0 (en) * | 1989-02-14 | 1989-04-05 | Ethical Pharma Ltd | Nifedipine-containing pharmaceutical compositions and process for the preparation thereof |
US5271944A (en) * | 1991-04-05 | 1993-12-21 | Biofor, Ltd. | Pharmacologically enhanced formulations |
DE4130173A1 (en) * | 1991-09-11 | 1993-03-18 | Bayer Ag | PHARMACEUTICAL PREPARATIONS WITH A SPECIAL CRYSTAL MODIFICATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4- (3-NITROPHENYL) -3,5-PYRIDINDICARBONIC ACID ISOPROPYL- (2-METHOXYETHYL) ESTER |
GB9200607D0 (en) * | 1992-01-13 | 1992-03-11 | Ethical Pharma Ltd | Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5773025A (en) | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US6726930B1 (en) | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5543099A (en) * | 1994-09-29 | 1996-08-06 | Hallmark Pharmaceutical, Inc. | Process to manufacture micronized nifedipine granules for sustained release medicaments |
DK0800392T3 (en) * | 1994-12-29 | 2002-03-18 | Shire Deutschland Gmbh & Co Kg | Pharmaceutical compositions containing nifedipine and its method of preparation |
JP3220373B2 (en) | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | Long-acting nifedipine preparation |
KR100321489B1 (en) | 1996-07-08 | 2002-10-09 | 에드워드 멘델 컴파니 인코포레이티드 | Sustained release matrix for high-dose insoluble drugs |
IT1284604B1 (en) * | 1996-09-27 | 1998-05-21 | Roberto Valducci | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING NIFEDIPINE AS THE ACTIVE SUBSTANCE |
US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
IL143375A0 (en) | 1999-09-30 | 2002-04-21 | Penwest Pharmaceuticals Co | Sustained release matrix systems for highly soluble drugs |
RU2378272C2 (en) | 2004-07-30 | 2010-01-10 | Торрент Фармасьютикалз Лимитед | Nebivolol and pharmaceutically acceptable salts thereof, method of producing said salts and nebivolol pharmaceutical compositions |
DE102004062475A1 (en) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Solid, orally administrable, modified release pharmaceutical dosage forms |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3330727A (en) * | 1960-04-19 | 1967-07-11 | Glaxo Lab Ltd | Griseofulvin with high specific surface area |
US3401221A (en) * | 1964-08-25 | 1968-09-10 | Norwich Pharma Co | Treatment of urinary tract infection |
DE2348334C2 (en) * | 1973-09-26 | 1982-11-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | New form of preparation of N-4- [2- (5-chloro-2-methoxybenzamido) ethyl] -phenyl-sulfonyl-N'-cyclohexylurea |
DE2400819C2 (en) * | 1974-01-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution |
GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
JPS55129221A (en) * | 1979-03-29 | 1980-10-06 | Kaken Pharmaceut Co Ltd | Preparation of oral preparation containing hardly soluble medicine |
CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
-
1980
- 1980-09-09 DE DE19803033919 patent/DE3033919A1/en not_active Ceased
- 1980-12-27 JP JP55185148A patent/JPS5914446B2/en not_active Expired
-
1981
- 1981-08-25 NO NO812879A patent/NO157368B/en unknown
- 1981-08-28 DE DE8181106729T patent/DE3161838D1/en not_active Expired
- 1981-08-28 EP EP81106729A patent/EP0047899B2/en not_active Expired - Lifetime
- 1981-08-28 AT AT81106729T patent/ATE5761T1/en not_active IP Right Cessation
- 1981-08-31 PT PT73603A patent/PT73603B/en unknown
- 1981-08-31 PH PH26121A patent/PH24097A/en unknown
- 1981-09-01 DD DD81232939A patent/DD201974A5/en not_active IP Right Cessation
- 1981-09-07 GR GR65968A patent/GR78237B/el unknown
- 1981-09-07 FI FI812758A patent/FI72648B/en not_active Application Discontinuation
- 1981-09-07 NZ NZ198285A patent/NZ198285A/en unknown
- 1981-09-07 IL IL63749A patent/IL63749A/en not_active IP Right Cessation
- 1981-09-08 AR AR286686A patent/AR226377A1/en active
- 1981-09-08 IE IE2075/81A patent/IE51549B1/en not_active IP Right Cessation
- 1981-09-08 CA CA000385365A patent/CA1180277A/en not_active Expired
- 1981-09-08 AU AU75063/81A patent/AU558331B2/en not_active Expired
- 1981-09-08 PL PL23295181A patent/PL232951A1/xx unknown
- 1981-09-08 DK DK396381A patent/DK154326C/en not_active IP Right Cessation
- 1981-09-08 ZA ZA816213A patent/ZA816213B/en unknown
- 1981-09-09 HU HU812594A patent/HU184879B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ198285A (en) | 1984-04-27 |
PH24097A (en) | 1990-03-05 |
IE51549B1 (en) | 1987-01-07 |
FI812758L (en) | 1982-03-10 |
DE3161838D1 (en) | 1984-02-09 |
DD201974A5 (en) | 1983-08-24 |
AU558331B2 (en) | 1987-01-29 |
FI72648B (en) | 1987-03-31 |
GR78237B (en) | 1984-09-26 |
IL63749A (en) | 1984-06-29 |
DK154326C (en) | 1995-03-13 |
HU184879B (en) | 1984-10-29 |
DE3033919A1 (en) | 1982-04-22 |
DK154326B (en) | 1988-11-07 |
EP0047899A1 (en) | 1982-03-24 |
ZA816213B (en) | 1982-09-29 |
NO157368B (en) | 1987-11-30 |
NO812879L (en) | 1982-03-10 |
EP0047899B2 (en) | 1996-02-28 |
JPS5914446B2 (en) | 1984-04-04 |
AU7506381A (en) | 1982-03-18 |
CA1180277A (en) | 1985-01-02 |
AR226377A1 (en) | 1982-06-30 |
EP0047899B1 (en) | 1984-01-04 |
PT73603B (en) | 1982-11-10 |
DK396381A (en) | 1982-03-10 |
JPS5750913A (en) | 1982-03-25 |
IL63749A0 (en) | 1981-12-31 |
ATE5761T1 (en) | 1984-01-15 |
PT73603A (en) | 1981-09-01 |
PL232951A1 (en) | 1982-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE812075L (en) | Composition | |
IL95691A0 (en) | Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them | |
IT8921118A0 (en) | COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT. | |
IL84446A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUT44135A (en) | Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components | |
HUT41203A (en) | Herbicide compositions containing 2-/2-comma above-substituted benzoyl/-1,3-cyclomexene-dione derivatives as active agents and process for producing the active agents | |
HUT39971A (en) | Pesticide compositions containing 3,5-diaryl-1,2,4-triazole derivatives as active ingredients and process for preparing the active substances | |
HUT41365A (en) | Insecticide compositions containing substituted benzyl-ether derivatives as active ingredients and process for preparing the active substances | |
HUT41213A (en) | Pesticide compositions containing benzodioxole derivatives as active ingredients and process for preparing the active compounds | |
HUT39568A (en) | Insecticide and acaricide compositions containing 13beta-alkyl-milbemycin derivatives as active ingredients further process for preparing the active substances | |
HUT44130A (en) | Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components | |
HUT38219A (en) | Herbicidal compositions comprising delta above 2-1,2,4-triazoline-5-on-derivatives as active substance and process for producing the active substance | |
HUT47793A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
AU476539B2 (en) | N-SULPHENYLATED N-METHYLCARBAMIDOXIMES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS INSECTICIDES ACARICIDES OR FUNGICIDES'i i v | |
HUT41230A (en) | Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents | |
HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
HUT44011A (en) | Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components | |
HUT41224A (en) | Herbicide compositions containing n-aryl-triazole derivatives as active substances and process for preparing the active substances | |
AU4864690A (en) | Substituted triaoles, their preparation and compositions, for use as fungicides | |
AU4482489A (en) | Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients | |
HUT47792A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
EP0226842A3 (en) | Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them | |
HUT46838A (en) | Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components | |
IL76685A0 (en) | 2-cyanobenzimidazole derivatives,preparation thereof and fungicidal and acaricidal compositions containing the same | |
EP0435186A3 (en) | Pyridyloxypyrimidine derivatives, preparation process thereof, and herbicidal compositions containing the same as active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |